Literature DB >> 3016625

Human papillomavirus and lower genital neoplasia in renal transplant patients.

R Halpert, R G Fruchter, A Sedlis, K Butt, J G Boyce, F H Sillman.   

Abstract

Lower genital cytopathology was evaluated in 105 immunosuppressed renal transplant recipients. Evidence of human papillomavirus infection was found in 17.5% and of lower genital neoplasia in 9.5%. The rate of the virus infection in the immunosuppressed was nine times greater than in a general population and 17 times greater than in a matched immunocompetent population. The rate of cervical neoplasia was 16 times greater than in a general population and nine times greater than in a matched immunocompetent population. In one-third of patients with human papillomavirus lesions and one-half of patients with neoplastic lesions, multiple lower genital sites were also involved. Of risk factors evaluated, only the number of sexual partners was associated with the development of human papillomavirus/lower genital neoplasia.

Entities:  

Mesh:

Year:  1986        PMID: 3016625

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  21 in total

1.  Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.

Authors:  Lisa G Johnson; Stephen M Schwartz; Mari Malkki; Qin Du; Effie W Petersdorf; Denise A Galloway; Margaret M Madeleine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-11       Impact factor: 4.254

Review 2.  Immunizations for renal transplant candidates and recipients.

Authors:  Jennifer Cohn; Emily A Blumberg
Journal:  Nat Clin Pract Nephrol       Date:  2008-11-25

3.  Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.

Authors:  K R Beutner; S K Tyring; K F Trofatter; J M Douglas; S Spruance; M L Owens; T L Fox; A J Hougham; K A Schmitt
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group.

Authors:  G Rezza; M Giuliani; M Branca; A Benedetto; G Migliore; A R Garbuglia; C D'Ubaldo; P Pezzotti; G Cappiello; D Pomponi Formiconi; B Suligoi; A Schiesari; G Ippolito; G Giacomini
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

Review 5.  The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.

Authors:  Lana E Kandalaft; Nathan Singh; John B Liao; Andrea Facciabene; Jonathan S Berek; Daniel J Powell; George Coukos
Journal:  Gynecol Oncol       Date:  2009-12-02       Impact factor: 5.482

6.  Risk of cervical intraepithelial neoplasia in women with glomerulonephritis.

Authors:  F Hartveit; B Bertelsen; S Thunold; B O Maehle; E Skaarland; J Christensen
Journal:  BMJ       Date:  1991-02-16

7.  Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Authors:  Shehnaz K Hussain; Margaret M Madeleine; Lisa G Johnson; Qin Du; Mari Malkki; Hui-Wen Wilkerson; Federico M Farin; Joseph J Carter; Denise A Galloway; Janet R Daling; Effie W Petersdorf; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

8.  Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine.

Authors:  Rebecca T Emeny; Cosette M Wheeler; Kathrin U Jansen; William C Hunt; Tong-Ming Fu; Judith F Smith; Stefani MacMullen; Mark T Esser; Xavier Paliard
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 9.  Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia.

Authors:  L Braun
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

10.  Single-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein.

Authors:  John B Liao; Jean Publicover; John K Rose; Daniel DiMaio
Journal:  Clin Vaccine Immunol       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.